Product analysis: the device remains implanted; therefore, no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that approximately 14 years and 2 months post implant of this bioprosthetic aortic root valve, a transcatheter valve was implanted valve-in-valve.It was reported that the right/left commissures of the bioprosthesis are fused, resulting in an acquired bicuspid valve.Diffuse calcification is present throughout the mid segment of the valve, particularly the leaflet in the right coronary sinus.The non-coronary leaflet was reported to be calcified, shortened and thickened.Leaflet opening is restricted, resulting in a severe lack of coaptation (8.5mm) between the coronary and non-coronary leaflets.There is "some degree" of hypoattenuating leaflet thickening.Pannus was reported below the leaflet in the right coronary sinus.No additional adverse patient effects were reported.
|